unresectable, recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

DBCOND0144293Neoplasms

unresectable, recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) is the indication for 1 drug in DrugBank. It is covered by 5 curated, structured indications.

Classified under: Neoplasms
Indicated drugs: Pembrolizumab

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for unresectable, recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account